Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas

Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Natalie M. Meléndez-Vázquez, Teresa T. Nguyen, Xuejun Fan, Andrés R. López-Rivas, Juan Fueyo, Candelaria Gomez-Manzano, Filipa Godoy-Vitorino
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Molecular Therapy: Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950329924000432
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas
by: Natalie M. Meléndez-Vázquez, et al.
Published: (2024-03-01)

Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas
by: Natalie M. Meléndez-Vázquez, et al.
Published: (2024-11-01)

Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota
by: Luis H. Pagan-Rivera, et al.
Published: (2024-12-01)

CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
by: Ye. L. Choinzonov, et al.
Published: (2014-06-01)

Evolution of radiotherapy and chemotherapy practice in malignant gliomas
by: Anusheel Munshi, et al.
Published: (2013-05-01)

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axis
by: Yang Qiao, et al.
Published: (2025-06-01)

The malignant transformation of an atypical angiocentric glioma, MYB-altered
by: Oumaima Aboubakr, et al.
Published: (2025-07-01)

Immunotherapy of malignant gliomas: a modern view on the problem
by: А. А. Pichugin, et al.
Published: (2024-12-01)

Predicting survival in malignant glioma using artificial intelligence
by: Wireko Andrew Awuah, et al.
Published: (2025-01-01)

Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy
by: Ignjatović Jelena, et al.
Published: (2015-01-01)

Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity
by: S. A. Kulyova, et al.
Published: (2021-12-01)

Optimizing Oncolytic Virotherapy for Malignant Glioma: From Bench to Bedside
by: Jiang W, et al.
Published: (2025-08-01)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
by: Victor A Levin, et al.
Published: (2018-04-01)

Identification of Malignant Progression of Gliomas through Metabolomics of Cerebrospinal Fluid and Serum
by: Mingzhe Zou, et al.
Published: (2025-08-01)

Immunotherapy for Malignant Gliomas: Overcoming Barriers and Defining Prospects for Integrated Approaches
by: O. A. Beylerli, et al.
Published: (2024-12-01)

The results of combined immunotherapy in integrated treatment of patients with malignant brain glioma
by: V. V. Stupak, et al.
Published: (2008-12-01)

Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
by: Anna Carolina Carvalho da Fonseca, et al.
Published: (2013-01-01)

Intraoperative Fluorescence Is Useful but Not Always Sufficient in Contrast-Enhancing Malignant Gliomas
by: Aliasgar V. Moiyadi
Published: (2018-04-01)

Cytodestructive Effects of Photodynamic Exposure in Primary Cultures of Malignant Glioma Cells
by: Volodymyr Rozumenko, et al.
Published: (2024-12-01)

Comprehensive analysis of microRNA expression profile in malignant glioma tissues
by: Monika Piwecka, et al.
Published: (2015-08-01)

Sonodynamic Therapy Using 5-Aminolevulinic Acid for Malignant Gliomas: A Review
by: Andrea Ebeling, et al.
Published: (2025-04-01)

Preliminary studies of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas
by: Clovis Orlando Pereira da Fonseca
Published: (2007-09-01)

Extrachromosomal DNA as a carrier of extra copies of oncogenes for heterogeneity and malignancy of glioma
by: Lin-jian Wang, et al.
Published: (2025-05-01)

Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
by: Shinjiro Fukami, et al.
Published: (2024-02-01)

Gut microbiota distinguishes aging hispanics with Alzheimer’s disease: associations with cognitive impairment and severity
by: Vanessa Sepúlveda-Rivera, et al.
Published: (2025-08-01)

Features of the microbiota for various malignant neoplasms
by: L. G. Solenova, et al.
Published: (2024-09-01)

Combination of Sodium Butyrate and Immunotherapy in Glioma: regulation of immunologically hot and cold tumors via gut microbiota and metabolites
by: Sui Li, et al.
Published: (2025-04-01)

New approaches in 3D modeling of in vitro growth of primary cultures of malignant gliomas
by: Yu. A. Khochenkova, et al.
Published: (2019-12-01)

APOBEC3C‐Mediated NF‐κB Activation Promotes Malignant Progression of Gliomas
by: Chao Zhang, et al.
Published: (2025-07-01)

MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12
by: Jie Zhang, et al.
Published: (2017-05-01)

Objectivic estimation metods of life quality at the patients with malignant brain glioma in dynamics of their complex treatment
by: I. V. Balayzin, et al.
Published: (2011-04-01)

FANCI is involved in the malignant progression of glioma cells by regulating the Akt/Bcl-2 signaling pathway
by: Hanyun Li, et al.
Published: (2025-05-01)

Mendelian randomization analysis of gut microbiota-immune cell interactions in malignant neoplasm of nasopharynx
by: Qicong Chen, et al.
Published: (2025-07-01)

Immunotherapy of antigen-presenting autologous dendrite cells in the complex treatment of patients with cerebral hemisphere malignant gliomas
by: S. P. Bajanov, et al.
Published: (2008-12-01)

A Case of Congenital Malignant Spinal Cord Glioma as a Cause of Congenital Ascites in a Neonate
by: Bianca Karber, et al.
Published: (2016-01-01)

A privacy-preserved horizontal federated learning for malignant glioma tumour detection using distributed data-silos.
by: Shagun Sharma, et al.
Published: (2025-01-01)

Differences in Intestinal Microbiota Between White and Common Cranes in the Yellow River Delta During Winter
by: Xiaodong Gao, et al.
Published: (2025-06-01)

RUNX2 mediated epithelial mesenchymal transition induced by TGF beta and Smad signaling promotes malignant progression in glioma
by: Peng Zhou, et al.
Published: (2025-07-01)

RETRACTED: Effect of radiotherapy and chemotherapy on levels of serum S100B, IL-6, and IL-17 in patients with malignant glioma
by: Chao Xiang, et al.
Published: (2018-10-01)

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up
by: Hao Duan, et al.
Published: (2024-12-01)